IRECO INCORPORATED – Trademark Portfolio

Entity Type: 03

IRECO INCORPORATED holds 31 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 13 (Firearms) — 31 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include TITAN, UNIGEL, BLASTEX, BLASTGEL, and TAMPTITE. The owner is based in SALT LAKE CITY, UT.

ELEVENTH FLOOR CROSSROADS TOWER

SALT LAKE CITY, UT 84144

31 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (31 results)

Trademark Classifications

IRECO INCORPORATED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

13
Firearms (31 filings)

Firearms; ammunition and projectiles; explosives; fireworks

37
Building & Construction (1 filing)

Building construction; repair; installation services

Frequently Asked Questions

How many trademarks does IRECO INCORPORATED have?

IRECO INCORPORATED has 31 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned, 24 cancelled.

What trademark classes does IRECO INCORPORATED file in?

IRECO INCORPORATED files trademarks across 2 Nice Classification classes. The most active classes are Class 13 (Firearms), Class 37 (Building & Construction). Class 13 covers firearms; ammunition and projectiles; explosives; fireworks.

What are IRECO INCORPORATED's most well-known trademarks?

IRECO INCORPORATED's registered trademark portfolio includes well-known marks such as TITAN, UNIGEL, BLASTEX, BLASTGEL, and TAMPTITE. These are among 6 currently registered trademarks in the portfolio.

What is IRECO INCORPORATED's trademark registration success rate?

IRECO INCORPORATED has a 19% trademark registration rate, with 6 out of 31 resolved applications resulting in successful registration. Currently, 0 applications are pending review.